Vialwirebiotech, curated
October 1, 2026, 11:29 AM
July 27, 2026
- 10:16 AM · BioPharma Dive10:16 AMSarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO — BioPharma Dive
- 9:46 AM · Pharmaceutical Executive9:46 AM<![CDATA[FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMAlmirall and Certest Biotec establish derma collaboration — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMAlzecure Pharma patents new UGT1A1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMBetta Pharmaceuticals reports new KRAS degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMInnovstone Therapeutics discloses new cathepsin C inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMCamp4 Therapeutics’ lead ASO approved for clinical trials in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMExeliris and Lin Gang Laboratory identify new PI3Kα inhibitors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMVeraxa Biotech advances bispecific ADC from Omniab collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMKelun-Biotech’s SKB-565 cleared to enter clinic in China — BioWorld
- 8:00 AM · STAT News
- 6:13 AM · Pharmaceutical Technology6:13 AMOutlook Therapeutics wins FDA approval for Lytenava in wet AMD — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMLeriglitazone gets positive EU opinion for rare neurodegenerative disease — Drug Discovery World
- 5:23 AM · Pharmaceutical Technology5:23 AMBiointron introduces RushData platform for AI-driven antibody discovery — Pharmaceutical Technology
- 4:58 AM · Pharmaceutical Technology4:58 AMKenvue’s Tylenol with Naproxen gains FDA approval — Pharmaceutical Technology
- 3:26 AM · STAT News3:26 AMSTAT+: Argenx to buy Forte Biosciences for $2.2B — STAT News
July 26, 2026
- 10:00 AM · SCMP — Tech10:00 AMChina has put a Polish university on its European dual-use exports blacklist. Why? — SCMP — Tech
- 9:30 AM · SCMP — Tech
- 7:00 AM · SCMP — Tech